PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of May 21, 2026, PRCT trades at $28.30 with a market cap of $1.48B and a P/E ratio of -16.03. PRCT moved +8.57% today. Year to date, PRCT is -15.13%; over the trailing twelve months it is -52.50%. Its 52-week range spans $19.35 to $103.81. Analyst consensus is buy with an average price target of $36.50. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading PRCT stock inside the company?
Recent PRCT insider activity includes Nouri Alaleh sold 3.03K, Nouri Alaleh sold 2.33K, Nouri Alaleh sold 304, Waters Kevin sold 706, and Nouri Alaleh sold 3.10K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
PRCT Key Metrics
Key financial metrics for PRCT
Metric
Value
Price
$28.30
Market Cap
$1.48B
P/E Ratio
-16.03
EPS
$-1.72
Dividend Yield
0.00%
52-Week High
$103.81
52-Week Low
$19.35
Volume
55
Avg Volume
0
Revenue (TTM)
$308.05M
Net Income
$-95.57M
Gross Margin
63.70%
Recent PRCT Insider Trades
Nouri Alaleh sold 3.03K (~$78.26K) on Mar 19, 2026.
Nouri Alaleh sold 2.33K (~$60.97K) on Mar 19, 2026.
Nouri Alaleh sold 304 (~$8.56K) on Mar 17, 2026.
Waters Kevin sold 706 (~$19.88K) on Mar 17, 2026.
Nouri Alaleh sold 3.10K (~$79.32K) on Mar 10, 2026.
Recent PRCT insider activity includes Nouri Alaleh sold 3.03K, Nouri Alaleh sold 2.33K, Nouri Alaleh sold 304, Waters Kevin sold 706, and Nouri Alaleh sold 3.10K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PRCT?
Yes. Rallies tracks PRCT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PRCT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRCT. It does not provide personalized investment advice.
